Literature DB >> 19121692

Seropositivity to Burkholderia pseudomallei does not reflect the development of cell-mediated immunity.

Sharon M Lazzaroni1, Jodie L Barnes, Natasha L Williams, Brenda L Govan, Robert E Norton, Justin T LaBrooy, Natkunam Ketheesan.   

Abstract

Cell-mediated immunity to Burkholderia pseudomallei, the causative agent of melioidosis, provides protection from disease progression. An indirect haemagglutination assay was used to detect antibodies to B. pseudomallei in 1500 healthy donors in an endemic region of Australia. Lymphocyte proliferation, activation and cytokine expression to B. pseudomallei antigen were determined in eight donors who were seropositive and in eight age- and sex-matched controls. In North Queensland, 2.5% of the population was seropositive for B. pseudomallei, which is less than half that which was previously described. Of clinical significance was the observation that while 75% of the seropositive individuals had increased lymphocyte proliferation to B. pseudomallei antigens, there were no significant differences observed in lymphocyte activation or production of cytokines.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19121692     DOI: 10.1016/S0035-9203(08)70018-X

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  5 in total

Review 1.  Human Melioidosis.

Authors:  I Gassiep; M Armstrong; R Norton
Journal:  Clin Microbiol Rev       Date:  2020-03-11       Impact factor: 26.132

2.  Clinical features that affect indirect-hemagglutination-assay responses to Burkholderia pseudomallei.

Authors:  Patrick N A Harris; Natkunam Ketheesan; Leigh Owens; Robert E Norton
Journal:  Clin Vaccine Immunol       Date:  2009-04-29

3.  Laboratory Safety: Handling Burkholderia pseudomallei Isolates without a Biosafety Cabinet.

Authors:  Ian Gassiep; Michelle J Bauer; Patrick N A Harris; Mark D Chatfield; Robert Norton
Journal:  J Clin Microbiol       Date:  2021-06-18       Impact factor: 5.948

4.  Development of vaccines against burkholderia pseudomallei.

Authors:  Natasha Patel; Laura Conejero; Melanie De Reynal; Anna Easton; Gregory J Bancroft; Richard W Titball
Journal:  Front Microbiol       Date:  2011-09-27       Impact factor: 5.640

5.  Detection of Burkholderia pseudomallei O-antigen serotypes in near-neighbor species.

Authors:  Joshua K Stone; Mark Mayo; Stephanie A Grasso; Jennifer L Ginther; Stephanie D Warrington; Christopher J Allender; Adina Doyle; Shalamar Georgia; Mirjam Kaestli; Stacey M Broomall; Mark A Karavis; Joseph M Insalaco; Kyle S Hubbard; Lauren A McNew; Henry S Gibbons; Bart J Currie; Paul Keim; Apichai Tuanyok
Journal:  BMC Microbiol       Date:  2012-11-05       Impact factor: 3.605

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.